Figure 6.
Post hoc analysis of the GATHER clinical program pooled data comparing risk reduction of patients with BCVA loss between ACP 2-mg and sham for ≥15 letter loss.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.